Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Cochrane database of systematic reviews, April 2012
Onland W, Offringa M, van Kaam A
Bronchopulmonary dysplasia (BPD), defined as oxygen dependence at 36 weeks postmenstrual age (PMA), remains an important complication of prematurity. Pulmonary inflammation plays a central role in the pathogenesis of BPD. Attenuating pulmonary inflammation with postnatal systemic corticosteroids reduces the incidence of BPD in preterm infants but may be associated with an increased risk of adverse neurodevelopmental outcomes. Local administration of corticosteroids via inhalation might be an effective and safe alternative.
|Readers by professional status||Count||As %|
|Student > Postgraduate||10||15%|
|Student > Master||10||15%|
|Student > Ph. D. Student||6||9%|
|Readers by discipline||Count||As %|
|Medicine and Dentistry||52||78%|
|Agricultural and Biological Sciences||3||4%|
|Economics, Econometrics and Finance||1||1%|
|Arts and Humanities||1||1%|